HD Biosciences, a WuXi AppTec company, is a prominent biology-focused contract research organization (CRO) specializing in plate-based assay development, high-throughput screening (HTS), leading lead optimization, and in vivo pharmacology. Their comprehensive drug discovery platform accelerates small molecule and biologic therapeutics across oncology, immunology, and metabolic disease pathways.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.